PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is an aggressive clinical phenotype characterized by the lack of expression (or minimal expression) of the estrogen receptor (ER) and progesterone receptor (PR) as well as the absence of the human epidermal growth factor receptor-2 (HER2).